Nasdaq: OVID
Ovid Therapeutics insiders
The officers, directors and 10% owners of Ovid Therapeutics Inc. who hold the most stock, valued at the live OVID price.
$2.34
OVID today +$80K (+3.54%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 2
- Their OVID stock
- $9.3M
- Market value
- $442M
- Held by ranked insiders
- 2.11%
Insiders by value of OVID holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Jeremy Levin | Executive Chairman | 3,770,509 | $8.8M | 2.00% | 9652nd |
| 2 | Stelios Papadopoulos | Director | 217,578 | $509K | 0.12% | 1636th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Ovid Therapeutics; see each profile for the filing.